Kai Hu
Academic / Other · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma (NPC), Locoregionally Advanced Nasopharyngeal Carcinoma, Adjuvant Therapy | Phase 2 | 2026-04-15 |
| Recruiting | A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Ly B-Cell Non-Hodgkin Lymphoma | Phase 1 | 2025-02-10 |